Skip to main content

CORRECTION article

Front. Pharmacol., 22 November 2023
Sec. Drugs Outcomes Research and Policies
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1336072

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

This article is a correction to:

  1. Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study

    1. Read original article
Geok Ying Chun,Geok Ying Chun1,2Nurul Ain Mohd Tahir Nurul Ain Mohd Tahir1*Farida IslahudinFarida Islahudin1Veena SelvaratnamVeena Selvaratnam3Shu Chuen LiShu Chuen Li4
  • 1Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  • 2Centre for Clinical Trial, Ampang Hospital, Ampang, Selangor, Malaysia
  • 3Hematology Department, Ampang Hospital, Ampang, Selangor, Malaysia
  • 4School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia

A Corrigendum on
Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

by Chun GY, Mohd Tahir NA, Islahudin F, Selvaratnam V and Li SC (2023). Front. Pharmacol. 14:1128887. doi: 10.3389/fphar.2023.1128887

In the published article, there was an error in the Funding statement. The name of the funder is missing (Ministry of Higher Education, Malaysia) and details of another funder is missing. The correct Funding statement appears below.

“The study acknowledges the Fundamental Research Grants Scheme (FRGS) [FRGS/1/2020/SS02/UKM/02/5] funded by the Ministry of Higher Education (MOHE), Malaysia, and part of this research is supported by the Geran Universiti Penyelidikan (GUP) funded by the Universiti Kebangsaan Malaysia, grant number GUP-2020-003”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: drug-related problems, thalassemia, MRCI, DRP, risk factors

Citation: Chun GY, Mohd Tahir NA, Islahudin F, Selvaratnam V and Li SC (2023) Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study. Front. Pharmacol. 14:1336072. doi: 10.3389/fphar.2023.1336072

Received: 10 November 2023; Accepted: 14 November 2023;
Published: 22 November 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Chun, Mohd Tahir, Islahudin, Selvaratnam and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Nurul Ain Mohd Tahir, nurulainmt@ukm.edu.my

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.